Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Three new cancer treatments are to be made available on the NHS in Scotland, as six drugs are given the green light for use.

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

In 2022, 79,906 women died due to cervical cancer. Know more about the challenges, treatment, prevention and progress of ...

Metastatic cervical cancer is treated with systemic therapy (chemotherapy, targeted therapy or immunotherapy). Outcomes of disease vary as per the nature of the healthcare facilities. The outcome ...

“Recurrent or metastatic cervical cancer remains a significant challenge for patients, highlighting a critical unmet need for effective treatments that extend survival after relapse,” said Dr ...

Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...

The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.

as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The approval means ...